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The treatment failure of Glioblastoma (GBM) is mostly due to the inadequate identification of 
its invasive margin. We aimed to characterize the peri-tumoral area, the predominant site of 
tumor progression by using multi-modal MRI. Thereafter, a robust method to preoperatively 
identify regions progression was developed. 
Methods: 
We retrospectively included 38 newly diagnosed cerebral glioblastoma patients. All patients 
were treated with 5-aminolevulinic acid (5-ALA) fluorescence guidance surgery and standard 
postoperative concomitant chemoradiotherapy. Preoperative MRI data acquisition was 
performed using a 3T MRI. Imaging included volumetric post contrast T1-weighted, perfusion 
MR, and DTI. DTI was decomposed into isotropic (p) component and anisotropic (q) 
components. Follow up MRI at time point of progression were co-registered to the 
preoperative MRI. Imaging characteristics of the peritumoral tumor progression regions were 
selected and compared to 5mm peri-tumoral non-progression regions. These imaging 
characteristics were then used to undergo convoluted neural network training which was 
further applied to develop an automated drawing of the tumor progression map on the 
preoperative MRI. 
Results: 
Multimodal MRI characterization 
FLAIR. In areas of later progression, there was significant increase in the FLAIR signal 
compared to non-progression area ( p  = 0.003) and control ( p  < 0.001).  
Diffusion MR. Characterizing isotropic p component showed a significant decrease in 
progression area than contrast enhanced area and non-progression area ( p  < 0.001). In 
areas of progression, anisotropic q was lower than non-progression peri-tumoral area ( p 
=0.001) and control ( p =0.009). The ADC values in the progression area were lower than 
peri-tumoral non-progression area ( p =0.008) and control ( p  < 0.001). Fractional anisotropy 
(FA) showed no difference between progression area and non-progression area ( p =0.537).  
DSC-MRI. Relative cerebral blood volume, compared to control, was increased in the 
contrast enhanced lesion and progression areas ( p <0.0001), but there was no difference in 
progression and non-progression area.  
Identification of the tumour progression 
By using the above significant imaging features to train the model, an average accuracy of 
85.1% with sensitivity of 86.5% and specificity of 83.8% was achieved using the convoluted 
neural network. Further application of the trained model can be used to generate predicted 
areas of progression on the preoperative MRI. 
Conclusion: 
Multimodal MR imaging, particularly diffusion tensor imaging, can demonstrate distinct 
characteristics in areas of potential progression on preoperative MRI. Moreover, by using 
these imaging features, the site of tumor progression can be identified and drawn 
automatically via a trained machine learning model which provides a direction for future study 
and treatment target. 
 
